Skip to content
10-Q

Quarterly Report

LUMOS PHARMA, INC.

0001126234-24-000097

← back to feed
Filed
Nov 7, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2024 · Nov 5, 2024 8.65M sh
Shares Diluted Q3 2024 · Sep 30, 2024 8.33M sh
Shares Diluted Q3 2024 · Sep 30, 2024 8.18M sh
Shares Diluted Q3 2024 · Sep 30, 2023 7.98M sh
Shares Diluted Q3 2024 · Sep 30, 2023 8.16M sh
Stock Repurchased Q3 2024 · Sep 30, 2024 $0
Stock Repurchased Q3 2024 · Sep 30, 2023 $1.31M
Operating Cash Flow Q3 2024 · Sep 30, 2024 −$24.28M
Operating Cash Flow Q3 2024 · Sep 30, 2023 −$23.7M
Short Term Investments Q3 2024 · Sep 30, 2024 $0
Short Term Investments Q3 2024 · Dec 31, 2023 $999K
Cash And Equivalents Q3 2024 · Sep 30, 2024 $13.52M
Cash And Equivalents Q3 2024 · Dec 31, 2023 $35.08M
Stockholders Equity Q3 2024 · Sep 30, 2024 $4.91M
Stockholders Equity Q3 2024 · Jun 30, 2024 $10.28M
Stockholders Equity Q3 2024 · Mar 31, 2024 $17.44M
Stockholders Equity Q3 2024 · Dec 31, 2023 $27.31M
Stockholders Equity Q3 2024 · Sep 30, 2023 $35.49M
Stockholders Equity Q3 2024 · Jun 30, 2023 $43.66M
Stockholders Equity Q3 2024 · Mar 31, 2023 $52.52M
Stockholders Equity Q3 2024 · Dec 31, 2022 $59.58M
Current Liabilities Q3 2024 · Sep 30, 2024 $6.51M
Current Liabilities Q3 2024 · Dec 31, 2023 $7.03M
Total Liabilities Q3 2024 · Sep 30, 2024 $12.55M
Total Liabilities Q3 2024 · Dec 31, 2023 $13.33M
Current Assets Q3 2024 · Sep 30, 2024 $17.27M
Current Assets Q3 2024 · Dec 31, 2023 $40.04M
Total Assets Q3 2024 · Sep 30, 2024 $17.46M
Total Assets Q3 2024 · Dec 31, 2023 $40.64M
Eps Diluted Q3 2024 · Sep 30, 2024 −$0.90
Eps Diluted Q3 2024 · Sep 30, 2024 −$3.11
Eps Diluted Q3 2024 · Sep 30, 2023 −$1.04
Eps Diluted Q3 2024 · Sep 30, 2023 −$3.01
Eps Basic Q3 2024 · Sep 30, 2024 −$0.90
Eps Basic Q3 2024 · Sep 30, 2024 −$3.11
Eps Basic Q3 2024 · Sep 30, 2023 −$1.04
Eps Basic Q3 2024 · Sep 30, 2023 −$3.01
Sga Expense Q3 2024 · Sep 30, 2024 $4.21M
Sga Expense Q3 2024 · Sep 30, 2024 $11.67M
Sga Expense Q3 2024 · Sep 30, 2023 $3.89M
Sga Expense Q3 2024 · Sep 30, 2023 $12.4M
Rd Expense Q3 2024 · Sep 30, 2024 $4.15M
Rd Expense Q3 2024 · Sep 30, 2024 $16.03M
Rd Expense Q3 2024 · Sep 30, 2023 $5.05M
Rd Expense Q3 2024 · Sep 30, 2023 $15.44M
Net Income Q3 2024 · Sep 30, 2024 −$7.47M
Net Income Q3 2024 · Sep 30, 2024 −$25.46M
Net Income Q3 2024 · Jun 30, 2024 −$7.55M
Net Income Q3 2024 · Mar 31, 2024 −$10.44M
Net Income Q3 2024 · Sep 30, 2023 −$8.3M
Net Income Q3 2024 · Sep 30, 2023 −$24.58M
Net Income Q3 2024 · Jun 30, 2023 −$8.93M
Net Income Q3 2024 · Mar 31, 2023 −$7.35M
Operating Income Q3 2024 · Sep 30, 2024 −$7.64M
Operating Income Q3 2024 · Sep 30, 2024 −$26.33M
Operating Income Q3 2024 · Sep 30, 2023 −$8.93M
Operating Income Q3 2024 · Sep 30, 2023 −$26.61M
Revenue Q3 2024 · Sep 30, 2024 $726K
Revenue Q3 2024 · Sep 30, 2024 $1.38M
Revenue Q3 2024 · Sep 30, 2023 $7K
Revenue Q3 2024 · Sep 30, 2023 $1.23M